Moderna News - September 1, 2026
Moderna Completes $3.0 Billion Offering of 0.00% Convertible Senior Notes Due 2032
Moderna has completed its previously announced private offering of $3.0 billion in aggregate principal amount of 0.00% Convertible Senior Notes due 2032. This...
🟢 Moderna is trading 10% up today after GSK advances mRNA flu vaccine
Moderna is trading at $154.38, up +10.01%, after GSK’s decision to advance an mRNA flu vaccine into Phase III was interpreted as validation of Moderna’s...
Moderna Faces GSK in Key mRNA Patent Hearing in The Hague
Moderna faces a patent infringement hearing today, September 1. The hearing is at the Unified Patent Court's local division in The Hague. GlaxoSmithKline...
🟢 Moderna is trading 4.6% up today with no clear catalyst identified
Moderna is trading 4.6% higher at $146.80, with no clear company-specific catalyst identified for the September 1, 2026 move. - The company announced upcoming...